References
- Fossa S. Aass N. Ous S. et al. 1989 Histology of residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer J. Urol. 142 1239 1242
- Eary J. 1999 Nuclear medicine in cancer diagnosis Lancet 354 853 857
- Toner G.C. Panicek D. Heelan R. et al. 1990 Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection J. Clin. Oncol. 8 1683 1694
- Baniel J. Foster R. Rowland R. Donahue J. 1994 Complications of primary retroperitoneal lymph node dissection J. Urol. 152 424 427
- Stephens A. Gonin R. Hutchins G. Einhorn L.H. 1996 Positron emission tomography evaluation of residual radiography abnormalities in post chemotherapy germ cell tumors J. Clin. Oncol. 15 1637 1641
- Nuutinen J.M. Leskinen S. Elomaa I. Minn H. Varpula M. Solin O. Soderstrom K.O. Joensuu H. Salminen E. 1997 Detection of residual tumors in post chemotherapy testicular cancer by FDG-PET Eur. J. Cancer 33 1234 1241
- Ganjoo K.N. Chan R.J. Sharma M. Einhorn L.H. 1999 Positron emission tomography scans in the evaluation of post chemotherapy residual masses in patients with seminoma J. Clin. Oncol. 17 3457 3460
- Santis M.D. Bokemeyer C. Becherer A. Stoiber F. Oechsle K. Kletter K. Dohmen B.M. Dittrich C. Pont J. 2001 Predictive impact of 2-18 fluoro-2-deoxy-D-glucose positron emission tomography for residual post chemotherapy masses in patients with bulky seminoma J. Clin. Oncol. 19 3740 3744
- Hain S.F. O'Doherty M.J. Timothy A.R. Leslie M.D. Harper P.G. Huddart R.A. 2000 Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumors at relapse Br. J. Cancer 83 863 869